SureTrader SureTrader
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

totally agree with that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 207
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma... "PR Newswire (US)" - 11/21/2016 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/18/2016 5:17:26 PM
ImmunoCellular Therapeutics Announces One-for-Forty Reverse Stock Split "PR Newswire (US)" - 11/16/2016 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 11/15/2016 6:23:31 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/10/2016 5:16:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/10/2016 4:17:41 PM
ImmunoCellular Therapeutics Announces Third Quarter 2016 Financial Results and Provides Research and Development Update "PR Newswire (US)" - 11/10/2016 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/4/2016 1:15:53 PM
ImmunoCellular Therapeutics to Report Third Quarter 2016 Financial Results on November 10, 2016 "PR Newswire (US)" - 11/2/2016 6:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 10/4/2016 4:20:36 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 10/4/2016 4:17:35 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 9/23/2016 4:18:14 PM
Cryoport and Database Integrations Launch Integrated Solution to Manage Patient and Manufacturer Schedules at Every Stage of ... "PR Newswire (US)" - 9/22/2016 4:15:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/16/2016 1:44:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/1/2016 4:49:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/22/2016 4:32:20 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/22/2016 4:08:58 PM
ImmunoCellular Therapeutics Announces Second Quarter 2016 Financial Results "PR Newswire (US)" - 8/22/2016 4:05:00 PM
ImmunoCellular Therapeutics to Report Second Quarter 2016 Financial Results on August 22, 2016 "PR Newswire (US)" - 8/17/2016 6:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/16/2016 6:08:03 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/16/2016 6:02:58 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 8/11/2016 6:09:21 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 8/11/2016 6:09:21 AM
ImmunoCellular Therapeutics Announces Pricing of $7.4 Million Public Offering "PR Newswire (US)" - 8/9/2016 8:45:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/9/2016 6:01:53 AM
biomanbaba  Grandfathered Member Friday, 05/11/12 08:47:45 PM
Re: fm112 post# 984
Post # of 3600 
totally agree with that

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist